Patent · US Active

Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof

US11414665B2 · kind B2 · utility

7Cited by
3References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2018
Grant dateAug 16, 2022
Priority date
Expiry dateNov 29, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are an siRNA for inhibiting expression of a Hepatitis B virus gene, and a pharmaceutical composition and conjugate containing the siRNA. Each nucleotide in the siRNA is an independently modified or unmodified nucleotide; the siRNA comprises a sense strand and an antisense strand; the sense strand comprises a nucleotide sequence A; the length of the nucleotide sequence A is the same as that of a nucleotide sequence as shown in SEQ ID NO: 1, and the number of the nucleotide differences is not more than three; the antisense strand comprises a nucleotide sequence B; and the length of the nucleotide sequence B is the same as that of a nucleotide sequence as shown in SEQ ID NO: 2, and number of nucleotide differences is not more than three.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.